According to our new research study on “Micropump Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by product type, material, application, end-user,” the market is expected to reach US$ 5,172.86 million by 2028 from US$ 1,553.01 million in 2021. A non-mechanical micropump employs forces directly on a liquid and have a limited flow rate, slower response compared to mechanical micropumps. However, they have shown to be very useful in drug delivery applications owing to their low power consumption. Non-mechanical micropumps are commonly used in micro devices because they can take advantage of physical properties of fluids when the volumes decrease to the micro-size and smaller.
The Global And China Microfluidic Devices Industry 2017 Market Research Report is a professional and in-depth study on the current state of the Microfluidic Devices industry.
Global Microfluidic Devices Market is estimated to reach $14.3 Billion by 2024; growing at a CAGR of 22.5% from 2016 to 2024. Microfluidic involves flow of liquid within micro-sized channels.
The Global And China Microfluidic Device Pumps Industry 2017 Market Research Report is a professional and in-depth study on the current state of the Microfluidic Device Pumps industry.
Widefield Imaging Systems Market: Japan Regional Market Projected to Witness 2.1X Growth in Terms of Revenue over the Forecast Period: Global Industry Analysis and Opportunity Assessment 2016–2026
The global venous blood collection devices market is expected to grow significantly during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2015 & 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Lab-On-a-Chip Market report segments global market by application, end-user, product, and technology – Global Industry Insights, Trends, Size, Share, Outlook, and Opportunity Analysis, 2017-2025
High number of research & development projects, increasing investments, and favorable regulatory policies are some other factors supporting growth of the market for pulmonary fibrosis treatment. Majority of the population living with pulmonary fibrosis is being treated with traditional corticosteroid combination drugs with limited efficacy. With the arrival of new novel therapies, unaddressed populations in middle- and lower-income countries, as well as developed countries, can offer significant revenue generation opportunities.
Global Microfluidic Devices Market size is projected to be valued $14 Billion by 2024; with a CAGR of 22.3% from 2017 to 2025. Microfluidics is an evolving scientific field with numerous analytical applications and commerci
Global microfluidic device demand outlook looks impressive for the years ahead, with the market expected to top US$ 21.5 Bn by the end of 2031. This industry survey by Persistence Market Research expects the microfluidic devices market to surge at a CAGR of around 24% over the forecast period of 2021-2031.
Medical Microfluidic Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Medical Microfluidic Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
The paper diagnostics Market Report offers a complete picture of industry trends and factors along with quantitative data based on historical data and from various sources. Apart from this, the report also provides the market outlook, growth, share, size, opportunity and forecast during 2019-2025. Further, the report focuses on competitive landscape including company profiles of leading key players along with industry demand, future capacities, key mergers & acquisitions, financial overview in the global market of paper diagnostics.
Microfluidic devices are referred to as lithographic devices utilized for the diagnosis or analysis of small volumes of fluids to perform the chemical, physiological and biological procedures. Microfluidics devices are gaining popularity across extensive range of diagnostic applications because of need of extremely low quantity of samples and efficiency in data interpretation in comparison to the traditional laboratory equipment.
The report Global Microfluidic Devices Industry 2016 Market Research Report covers the whole industry outlook with value chain analysis, DRO's, production and sales volumes and figures.
The global microfluidic device market was valued at USD 1,531.2 million in 2013. It is likely to grow at a CAGR of 22.8% during 2013 to 2019 to reach USD 5,246.4 million in 2019.
Global Micro-Electro-Mechanical System (MEMS) Market accounted for USD 10.2 billion in 2016 growing at a CAGR of 10.6% during the forecast period of 2017 to 2024.
Global Micro-pump Information, by Type (Mechanical & Non-Mechanical and others), by applications (drug delivery, biomedical, infusion and others) by end users (Hospitals, Clinics, Diagnostic Centers and others) - Forecast to 2027
The global venous blood collection devices market is expected to grow significantly during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2015 & 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Global vitamin deficiency treatment market is expected to rise from its initial estimated value by registering a substantial CAGR during the forecast period of 2019-2026. This rise in market value can be attributed to the increased awareness towards health of people globally. The report contains data of the base year 2018 and historic year 2017.
BioMEMS devices deployed in hospitals and healthcare facilities are primarily focused on medical screening and diagnostic applications, such as devices that measure point-of-care parameters. Wearable devices that facilitate and assure continuous monitoring without hampering a user’s freedom of movement are being bolstered through new opportunities offered by innovative sensors for human biomedical signal acquisition coupled with wireless connectivity and low power solutions. In addition, greater attention is being accorded to diagnostic MEMS sensors that can assist in performing critical functions, such as cholesterol monitoring, pregnancy monitoring, food allergy detection and DNA analyses. Sensor technologies in several cases provide crucial outcomes and form a major element in the process of assisting in decision-making before obtaining formal clinical intervention and care.
Microfluidics Market by Product (Devices, Components (Chip, Sensor, Pump, Valve)), Application (IVD (POC, Clinical, Veterinary), Research, Manufacturing, Therapeutics), End User (Hospital, Diagnostic Center, Academic Institutes), and Region (North America, Europe, Asia-Pacific, Middle East and Africa and South America)
The microfluidics market is expected to witness market growth at a rate of 23.42% in the forecast period of 2022 to 2029. Data Bridge Market Research report on microfluidics market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth.
Microfluidics Market: Point of Care Testing Segment Anticipated to Register High Revenue Growth over the Forecast Period: Global Industry Analysis and Opportunity Assessment 2016–2026
Market Size – USD 20.14 Billion in 2021, Market Growth – at a CAGR of 16.1%, Market Trends – Increasing application of microfluidic platforms in various healthcare industries
According to the latest research report by IMARC Group, The global microfluidics market size reached US$ 24.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 61.0 Billion by 2028, exhibiting a growth rate (CAGR) of 16.2% during 2023-2028. More Info:- https://www.imarcgroup.com/microfluidics-market
The Global Biochips Market size is expected to reach $20.3 billion by 2025, rising at a market growth of 11.2% CAGR during the forecast period. Biochips are miniaturized medical devices used within molecular laboratories to conduct simultaneous biochemical reactions. These devices can rapidly screen multiple biological analytes for several applications like disease diagnosis and identification of hazardous biological agents existing in systems. Their design is based on microarray and microfluidic technologies. Among the two, digital microfluidic biochip has surfaced as a highly efficient chip and has gained huge traction in the biochemical industry. Full Report: https://www.kbvresearch.com/biochips-market/
Microfluidics is a medical approach involving the precise control of small fluid samples for medical analysis. The sample sizes in microfluidics range from microliters to picolitres. At such low volumes, the transportation of fluid is governed significantly by its mass.
According to the latest research report by IMARC Group, The global microfluidics market size reached US$ 24.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 61.0 Billion by 2028, exhibiting a growth rate (CAGR) of 16.2% during 2023-2028. More Info:- https://www.imarcgroup.com/microfluidics-market
Global paper diagnostics market size is expected to reach $14.49 Bn by 2028 at a rate of 9.7%, segmented as by product, dipsticks, lateral flow assays, paper based microfluidics
The Global Microfluidics Market report 2018-2024, has been prepared By Axiom Market Research & Consulting, based on a deep market analysis with inputs from industry experts. This report covers market landscape, strategies, merger & acquisition, size, key competitors, company profiles, progressive technological advancement, and expansion of production, segmentation, production, revenue and its growth prospects for the upcoming years.
The organ-on-chip market consists of sales of organs-on-chips by entities (organizations, sole traders and partnerships) that manufacture organs-on-chips used for drug development, toxicity testing, and personalized medicine research. Organs-on-chips (OOCs) are small plastic devices with biocompatible microfluidic chambers containing multiple live human cells in a 3D culture that simulate key physiological functions of body organs. Organs-on-chips that mimic the organ level physiology of humans are a promising alternative to animal models.
The global microfluidics market size reached US$ 20.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 52.4 Billion by 2027, exhibiting a CAGR of 16.47% during 2022-2027. More info:- https://www.imarcgroup.com/microfluidics-market
The global cell-free fetal DNA testing market is forecast to expand at a CAGR of 10% and thereby increase from a value of US$1.5 Bn in 2023, to US$2.9 Bn by the end of 2030.
he global market for veterinary diagnostic is estimated to progress at 7.71% CAGR throughout 2019-2027 and will generate revenue of $5,129 million by the end of 2027. The heavy demand for livestock products is partly responsible for the steady increase in market growth over the years.Know more @ https://www.inkwoodresearch.com/reports/north-america-veterinary-diagnostics-market/
This report studies the global microfluidics market over the forecast period of 2013 to 2018.The global microfluidics market is valued at $1.59 billion in 2013 and is poised to reach $3.57 billion by 2018, at a CAGR of 17.6%.
With 14.5% CAGR, point of care testing segment is the largest segment among the global microfluidics market application segments By the end of 2026, the point of care testing segment is projected to reach more than US$ 3,000 Mn in revenue and is estimated to grow 3.9x by 2026 end as compared to that in 2016. The point of care testing segment is the largest segment among the different application segments in the global microfluidics market, which was estimated to create close to US$ 1,000 Mn or 33.2% share of the total market in 2016. This segment is anticipated to register a CAGR of 14.5% over the forecast period.
The Point of Care Diagnostic Devices Market has changed the game because earlier, a medical sample had to be sent away from the patient for hours, sometimes for days, before the results were known. During this delay, the patient has to be treated without the necessary information.
The global venous blood collection devices market is expected to grow significantly during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2015 & 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Hyperbaric oxygen therapy (HBOT) devices are used for delivering pure oxygen (100%) to tissues in the body under higher atmospheric pressure. Atmospheric pressure in hyperbaric oxygen chambers or devices is increased from one to three times higher than normal atmospheric pressure which in turns fight bacteria and also stimulates the release of a substance called growth factors and stem cells promoting healing.
The Global Microfluidic Device Industry 2015 Deep Market Research Report is a professional and in-depth study on the current state of the Microfluidic Device industry.
According to the latest research report by IMARC Group, The global PMMA microspheres market size reached US$ 356.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 803.8 Billion by 2032, exhibiting a growth rate (CAGR) of 9.16% during 2024-2032. More Info:- https://www.imarcgroup.com/pmma-microspheres-market
The research reports on “Maskless Lithography System Market” report gives detailed overview of factors that affect global business scope. Maskless Lithography System Market report shows the latest market insights with upcoming trends and breakdowns of products and services. This report provides statistics on the market situation, size, regions and growth factors. An exclusive data offered in this report is collected by research and industry experts team. Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=6957498
Request for an in-depth table of contents for this report @ https://www.gminsights.com/request-toc/upcoming/344 BioMEMS or bio-medical micro electro mechanical systems market has emerged as a division of MEMS devices for applications in medical micro devices and biomedical research. It offers various benefits such as it improves medical device performance for the patient and offers competitive advantages to system manufacturers.
According to the latest research report by IMARC Group, The global biochips market size reached US$ 19.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 64.3 Billion by 2032, exhibiting a growth rate (CAGR) of 13.7% during 2024-2032. More Info:- https://www.imarcgroup.com/biochips-market
According to the latest research report by IMARC Group, The global organ-on-chip market size reached US$ 61.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 541.8 Million by 2032, exhibiting a growth rate (CAGR) of 26.5% during 2024-2032. More Info:- https://www.imarcgroup.com/organ-on-chip-market
According to the latest research report by IMARC Group, The global automotive actuators market size reached US$ 28.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 44.6 Billion by 2032, exhibiting a growth rate (CAGR) of 5.1% during 2024-2032. More Info:- https://www.imarcgroup.com/automotive-actuators-market